In this week's video, Dr. Brian Durie discusses the first monoclonal antibody approved for myeloma treatment - Darzalex (daratumumab).
Darzalex is a useful drug that has some drawbacks in terms of testing.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.